Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone and androgens for glucocorticoid-induced protein catabolism
2005-003750-10Phase 2Active
- Sponsor
- Region Västra Götaland
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of somatropin and AndroForte in cachexia, polymyalgia rheumatica (PMR) and autoimmune arthritis (3 arms), sponsored by Region Västra Götaland. Primary endpoints: Change in protein breakdown, Change in protein oxidation and 1 more. Started Aug 2005; status: active.
02
Drugs
somatropinAndroForte
03
Conditions
cachexiapolymyalgia rheumatica (PMR)autoimmune arthritis
Beyond the preview
Go deeper on 2005-003750-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003750-10.